VCX-48100-97514
2 vaccinations
2 coded responses
11 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 950 / CA
- Registered
- 2021-09-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-06
Dose 1 — Pfizer-BioNTech
-
2021-09-11
Registered in v-safe
- 2021-09-11
- 2021-09-12
- 2021-09-13
-
2021-09-21
Survey response — day 14, dose 1MedDRA: Malaise, Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sickness-coldMedDRA releases: 2024-11 · check-in free text available
-
2021-09-27
Dose 2 — Pfizer-BioNTech
- 2021-10-04
- 2021-10-13
- 2021-10-18
- 2021-10-26
- 2021-11-11
- 2021-12-27
-
2022-03-30
Survey response — 6 months, dose 2MedDRA: Eyelid margin crusting, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose congestion sore throat crusty eye after vaccineMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-06 | Pfizer-BioNTech | No |
| 2 | 2021-09-27 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 1
Symptoms: Sickness-cold
Release 11 — 6 months, dose 2
Symptoms: Runny nose congestion sore throat crusty eye after vaccine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eyelid margin crusting | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release